{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-339389","form_type":"8-K","ticker":"TEVA","cik":"0000818686","company_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","filed_at":"2021-11-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.694850+00:00","generated_at":"2026-06-28T05:37:20.311456+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Teva appoints Amir Weiss as Chief Accounting Officer, replacing Andrew Weil","bullets":["Andrew Weil steps down as Chief Accounting Officer effective November 24, 2021.","Amir Weiss promoted from VP Finance and Corporate Controller to SVP and Chief Accounting Officer, effective same date.","Weiss's base salary increased to 840,000 NIS; eligible for 50% target annual cash incentive and equity awards.","Weiss joined Teva in 2012 and holds an MA in law, MBA, and CPA."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-339389","json":"https://secwatch.observer/filing/0001193125-21-339389.json","markdown":"https://secwatch.observer/filing/0001193125-21-339389.md","text":"https://secwatch.observer/filing/0001193125-21-339389.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818686/000119312521339389/0001193125-21-339389-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818686/000119312521339389/d222550d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T05:37:20.311456+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6b197056bf","claim":"Amir Weiss was appointed as Senior Vice President and Chief Accounting Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD.","evidence_excerpt":"Amir Weiss, currently Vice President of Finance and Corporate Controller, was promoted to Senior Vice President and Chief Accounting Officer, effective November 24, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/818686/000119312521339389/0001193125-21-339389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Senior Vice President and Chief Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"94d63bb307","claim":"Andrew Weil departed as Chief Accounting Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD.","evidence_excerpt":"Andrew Weil, Teva’s Chief Accounting Officer, will step down from his role as Chief Accounting Officer, effective November 24, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/818686/000119312521339389/0001193125-21-339389-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Chief Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}